2013
Requests for reprints can be addressed to:
Avanti A, Saluja V, Streun van ELP, Frijlink HW, Hinrichs WLJ
Stability of lysozyme in aqueous extremolyte solutions during heat shock and accelerated thermal conditions
Jesus de MB, Radaic A, Hinrichs WLJ, Ferreira CV, de Paula E, Hoekstra D, Zuhorn IS
Inclusion of the helper lipid dioleoyl-phosphatidylethanolamine in solid lipid nanoparticles inhibits their transfection efficiency
Journal of Biomedical Nanotechnology, 2014, 10, 355-365
Murugappan S, Patil HP, Frijlink HW, Huckriede A, Hinrichs WLJ
Simplifying Influenza Vaccination during Pandemics: Sublingual Priming and Intramuscular Boosting of Immune Responses with Heterologous Whole Inactivated Influenza Vaccine
AAPS J, accepted for publication
Patil HP, Murugappan S, Veer ter W, Meijerhof T, Haan de A, Frijlink HW, Wilschut J, Hinrichs WLJ, Huckriede A
Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine
Journal of Controlled Release, 2014, 174, 51–62
Tonnis WF, Amorij JP, Kersten GF, Frijlink HW, Hinrichs WLJ
Improved storage stability and immunogenicity of hepatitis B vaccine after spray-freeze drying in presence of sugars
European Journal of Pharmaceutics Sciences, accepted for publication
Avanti C, Hinrichs WLJ, Casini A, Eissens AC, van Dam A, Kedrov A, Driessen AJM, Frijlink HW, Permentier HP
The formation of oxytocin dimers is suppressed by the zinc-aspartate-oxytocin complex
Journal of Pharmaceutical Sciences, 2013, 102, 1734-1741
Avanti C, Oktaviani NA, Hinrichs WLJ, Frijlink HW, Mulder FAA
Aspartate buffer and divalent metal ions affect the oxytocin in aqueous solution and protect it from degradation
International Journal of Pharmaceutics, 2013, 444, 139-145
Godoy P, Hewitt N J, Albrecht U, Andersen ME, Ansari N, Bhattacharya S, Bode JG, Bolleyn J, Borner C, Bottger J, Braeuning A, Budinsky RA, Burkhardt B, Cameron NR, Camussi G, Cho CS, Choi YJ, Craig Rowlands J, Dahmen U, Damm G, Dirsch O, Donato MT, Dong J, Dooley, S, Drasdo D, Eakins R, Ferreira KS, Fonsato V, Fraczek J, Gebhardt R, Gibson A, Glanemann M, Goldring, CE, Gomez-Lechon MJ, Groothuis GM, Gustavsson L, Guyot C, Hallifax D, Hammad S, Hayward A, Haussinger D, Hellerbrand C, Hewitt P, Hoehme S, Holzhutter HG, Houston JB, Hrach J, Ito K, Jaeschke H, Keitel V, Kelm JM, Kevin Park B, Kordes C, Kullak-Ublick GA, LeCluyse EL, Lu P, Luebke-Wheeler J, Lutz A, Maltman DJ, Matz-Soja M, McMullen, P, Merfort I, Messner S, Meyer C, Mwinyi J, Naisbitt DJ, Nussler AK, Olinga P, Pampaloni F, Pi J. Pluta L, Przyborski SA, Ramachandran A, Rogiers V, Rowe C, Schelcher C, Schmich K, Schwarz M, Singh B, Stelzer EH, Stieger B, Stober R, Sugiyama Y, Tetta C, Thasler WE, Vanhaecke T, Vinken M, Weiss TS, Widera A, Woods CG, Xu JJ, Yarborough KM, Hengstler JG
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
Archives of Toxicology, 2013, 87, 1315-530
Grasmeijer F, Hagedoorn P, Frijlink HW, de Boer AH
The effect of mixing time on drug agglomeration and detachment for adhesive mixtures containing fine lactose carriers
Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2013, 26, A7-A7
Grasmeijer F, Hagedoorn P, Frijlink HW, de Boer AH
The effect of mixing time on drug agglomeration and detachment for adhesive mixtures containing coarse lactose carriers
Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2013, 26, A7-A7
Grasmeijer F, Hagedoorn P, Frijlink HW, de Boer AH
Carrier payload affects drug particle detachment from carriers in adhesive mixtures for inhalation
Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2013, 26, A239-A239
Grasmeijer F, Hagedoorn P, Frijlink HW, de Boer AH
Drug Content Effects on the Dispersion Performance of Adhesive Mixtures for Inhalation
Grasmeijer F, Hagedoorn P, Frijlink HW, de Boer AH
Mixing Time Effects on the Dispersion Performance of Adhesive Mixtures for Inhalation
Grasmeijer N, Stanković M, de Waard H, Frijlink HW, Hinrichs WLJ
Unravelling protein stabilization mechanisms: vitrification and water replacement in a glass transition temperature controlled system
Biochimica et Biophysica Acta - Proteins and Proteomics, 2013, 1834, 763-769
Grasmeijer N, de Waard H, Hinrichs WLJ, Frijlink HW
A user friendly model for spray drying to aid pharmaceutical product development
Hagedoorn P, Grasmeijer F, van den Noort M, Frijlink HW, de Boer AH
The effect of mixing time on dispersion performance of carrier based mixtures in relation to initial carrier payload
Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2013, 26, A240-A240
Hoppentocht M, Hagedoorn, P, Frijlink HW, de Boer AH
Developments and strategies for inhaled antibiotic drugs in tuberculosis therapy: A critical evaluation
European Journal of Pharmaceutics and Biopharmaceutics, available online
Hoppentocht M, Hagedoorn P, Frijlink HW, de Boer AH
Formulation of dry powder tobramycin for the twincer (tm) high dose, disposable inhaler
Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2013, 26, A237-A237
Ingvarsson PT, Schmidt ST, Christensen D, Larsen NB, Hinrichs WLJ, Andersen P, Rantanen J, Nielsen HM, Yang M, Fogeda C
Designing CAF-adjuvanted dry powder vaccines: Spray drying preserves the adjuvant activity of CAF01
Journal of Controlled Release, 2013, 167, 256–264
Lexmond AJ, Hagedoorn, P, Frijlink HW, de Boer AH
Challenging the Two-Minute Tidal Breathing Challenge Test
Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2013, 26, 380-386
Lexmond AJ, Hagedoorn, P, Frijlink HW, Ten Hacken NH, Steckel H, de Boer AH
Dry powder formulation in the twincer (tm) for bronchial challenge testing
Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2013, 26, A241-A241
Lexmond AJ, Hagedoorn, P, Frijlink HW, de Boer AH
Challenges in bronchial challenge testing
Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2013, 26, A17-A18
Lexmond AJ, Kruizinga TJ, Hagedoorn, P, Frijlink HW, Rottier BL, de Boer AH
Investigation of the applicability of dry powder inhalation in school children
Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2013, 26, A56-A56
Lexmond A J, Hagedoorn P, van der Wiel E, Ten Hacken NH, Frijlink HW, de Boer AH
Adenosine dry powder inhalation for bronchial challenge testing, part 1: Inhaler and formulation development and in vitro performance testing
European Journal of Pharmaceutics and Biopharmaceutics, available online
Maurer JM, Schellekens R C, van Rieke, HM, Stellaard, F, Wutzke, KD, Buurman, DJ, Dijkstra G, Woerdenbag HJ, Frijlink, HW, Kosterink, JG
ColoPulse tablets perform comparably in healthy volunteers and Crohn's patients and show no influence of food and time of food intake on bioavailability
Journal of Controlled Release, 2013, 172, 618-624
Murugappan S, Patil HP, Kanojia G, Veer ter W, Mijerhof T, Frijlink HW, Huckriede A, Hinrichs WLJ
Physical and immunogenic stability of spray freeze dried influenza vaccine powder for pulmonary delivery: comparison of inulin, dextran or a mixture of dextran and trehalose as protectants
European Journal of Pharmaceutics and Biopharmaceutics, 2013, 85, 716-725
Olinga P, Schuppan D
Precision-cut liver slices: a tool to model the liver ex vivo
Journal of hepatology, 2013, 58, 1252-1253
Pham BT, Oosterhuis D, Rieder F, Olinga P
Mouse Strain Differences in the Early Onset of Intestinal Fibrosis Using Ex Vivo Precision-Cut Intestinal Slices
Gastroenterology, 2013, 144, S672-672
Pham BT, Westra I, Oosterhuis D, de Graaf I, Olinga P
Rat and human intestinal slices as a model for intestinal fibrosis in Inflammatory Bowel Disease
Gastroenterology, 2013, 144, S672-672
Siissalo S, de Waard H, de Jager MH, Hayeshi R, Frijlink HW, Hinrichs WLJ, Dinter-Heidorn H, van Dam A, Proost JH, Groothuis GMM, de Graaf IAM
Nanoparticle formulation of a poorly soluble CB-1 antagonist improves absorption by rat and human intestine
Drug Metabolism and Disposition, 2013, 41, 1557-1565, 2013
Stanković M, de Waard H, Steendam R, Hiemstra C, Zuidema J, Frijlink HW, Hinrichs WLJ
Low temperature extruded implants based on novel hydrophilic multiblock copolymer for long-term protein delivery
European Journal of Pharmaceutics and Sciences, 2013, 49, 578–587
Tonnis WF, Lexmond AJ, Frijlink HW, de Boer AH, Hinrichs WLJ
Devices and formulations for pulmonary vaccination
Expert Opinion on Drug Delivery, 2013, 10, 1383-1397
Tonnis WF, Lexmond AJ, Frijlink HW, de Boer AH, Hinrichs WLJ
Rebuttal from the authors
Expert Opinion on Drug Delivery, 2013, 10, 1594-1595
Wahjudi M, Murugappan S, van Merkerk R, Eissens AC, Visser MR, Hinrichs WLJ, Quax WJ
Development of a dry, stable and inhalable PvdQ powder formulation for the treatment of pulmonary Pseudomonas aeruginosa infections
European Journal of Pharmaceutics and Sciences, 2013, 48, 637-643
Werkhoven van MB, Damman J, van Dijk MC, Daha, MR, de Jong IJ, Leliveld A, Krikke C, Leuvenink HG, van Goor H, van Son W J, Olinga P, Hillebrands JL, Seelen MA
Complement mediated renal inflammation induced by donor brain death: role of renal C5a-C5aR interaction
American journal of transplantation, 2013, 13, 875-882
Westra IM, Pham BT, Groothuis GM, Olinga P
Evaluation of fibrosis in precision-cut tissue slices
Willemsz TA, Nguyen TT, Hooijmaijers R, Frijlink HW, Vromans H ,van der Voort Maarschalk K
Quantitative Characterization of Agglomerate Abrasion in a Tumbling Blender
by Using the Stokes Number Approach
AAPS PharmSciTech, 2013, 14, 183-188
| Laatst gewijzigd: | 24 januari 2014 09:42 |